These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 12388489

  • 1. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA, Caputo GR, Steinbach LS.
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [Abstract] [Full Text] [Related]

  • 2. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.
    Cancer; 2013 Mar 15; 119(6):1227-34. PubMed ID: 23233156
    [Abstract] [Full Text] [Related]

  • 3. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 15; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 4. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
    van Laarhoven HW, de Geus-Oei LF, Wiering B, Lok J, Rijpkema M, Kaanders JH, Krabbe PF, Ruers T, Punt CJ, van der Kogel AJ, Oyen WJ, Heerschap A.
    Radiology; 2005 Oct 15; 237(1):181-8. PubMed ID: 16183932
    [Abstract] [Full Text] [Related]

  • 5. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec 15; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 6. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
    Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE.
    Radiology; 2007 Dec 15; 245(3):839-47. PubMed ID: 18024454
    [Abstract] [Full Text] [Related]

  • 7. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
    Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M.
    Radiology; 2008 Oct 15; 249(1):203-11. PubMed ID: 18710963
    [Abstract] [Full Text] [Related]

  • 8. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F, Federman N, Apichairuk W, Nelson S, Phelps ME, Allen-Auerbach M, Walter MA, Czernin J.
    Pediatr Hematol Oncol; 2011 Oct 15; 28(7):579-87. PubMed ID: 21936620
    [Abstract] [Full Text] [Related]

  • 9. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
    Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Möttönen T, Nuutila P, Minn H.
    Arthritis Rheum; 2003 Nov 15; 48(11):3077-84. PubMed ID: 14613269
    [Abstract] [Full Text] [Related]

  • 10. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
    Yen RF, Hung RL, Pan MH, Wang YH, Huang KM, Lui LT, Kao CH.
    Cancer; 2003 Jul 15; 98(2):283-7. PubMed ID: 12872346
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss LG, Zhang YM, Mechtersheimer G, Attigah N, Lehnert T, Herfarth C.
    Ann Surg; 2000 Mar 15; 231(3):380-6. PubMed ID: 10714631
    [Abstract] [Full Text] [Related]

  • 12. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC.
    AJR Am J Roentgenol; 1995 Sep 15; 165(3):593-8. PubMed ID: 7645476
    [Abstract] [Full Text] [Related]

  • 13. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE.
    Radiology; 1999 Mar 15; 210(3):807-14. PubMed ID: 10207485
    [Abstract] [Full Text] [Related]

  • 14. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.
    Del Grande F, Subhawong T, Weber K, Aro M, Mugera C, Fayad LM.
    Radiology; 2014 May 15; 271(2):499-511. PubMed ID: 24495264
    [Abstract] [Full Text] [Related]

  • 15. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T, Saito K, Kiyohara H, Ohno T, Nakano T, Takagishi K.
    Radiat Oncol; 2015 Dec 21; 10():259. PubMed ID: 26691334
    [Abstract] [Full Text] [Related]

  • 16. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S, Marcus C, Hafezi-Nejad N, Taghipour M, Subramaniam RM.
    PET Clin; 2015 Jul 21; 10(3):375-93. PubMed ID: 26099673
    [Abstract] [Full Text] [Related]

  • 17. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
    Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ.
    Cancer Treat Rev; 2004 Feb 21; 30(1):83-101. PubMed ID: 14766127
    [Abstract] [Full Text] [Related]

  • 18. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
    Dancheva Z, Bochev P, Chaushev B, Yordanova T, Klisarova A.
    Nucl Med Rev Cent East Eur; 2016 Feb 21; 19(1):22-7. PubMed ID: 26841376
    [Abstract] [Full Text] [Related]

  • 19. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, Taminiau AH, van Coevorden F, Zwinderman AH, Pope TL, Bloem JL.
    Radiology; 2004 Nov 21; 233(2):493-502. PubMed ID: 15459325
    [Abstract] [Full Text] [Related]

  • 20. Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.
    Soldatos T, Ahlawat S, Montgomery E, Chalian M, Jacobs MA, Fayad LM.
    Radiology; 2016 Mar 21; 278(3):831-40. PubMed ID: 26390048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.